fluphenazine has been researched along with Infections, Coronavirus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sinha, S | 1 |
| Cheng, K | 1 |
| Schäffer, AA | 1 |
| Aldape, K | 1 |
| Schiff, E | 1 |
| Ruppin, E | 1 |
| Otręba, M | 1 |
| Kośmider, L | 1 |
| Rzepecka-Stojko, A | 1 |
1 review available for fluphenazine and Infections, Coronavirus
| Article | Year |
|---|---|
Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review.
Topics: Animals; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Chlorpromazine; Coronavirus Infect | 2020 |
1 other study available for fluphenazine and Infections, Coronavirus
| Article | Year |
|---|---|
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.
Topics: A549 Cells; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Convertin | 2020 |